Search

Search results

Current filters: Hepatitis C drugs, Treatment, Drug treatment strategies

7 search results

Sofosbuvir + velpatasvir + voxilaprevir (Vosevi) for people with genotypes 1, 2 or 3 whose previous treatment failed

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir + voxilaprevir (Vosevi) for HCV re-treatment

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

The Hep C Revolution

From The Positive Side - Fall 2016
2016, CATIE
Client resources - Webpage

Sofosbuvir + velpatasvir – interactions with other medicines

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir (Epclusa) + ribavirin for retreatment

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Modest effectiveness of short-course therapy in cases of advanced HCV-related liver injury

2015, CATIE
Research summary - Webpage

Hep Drug Interactions

2018, University of Liverpool
Website - Webpage
More info